Began Marc A
EVP & General Counsel at AXGN; VP & GENERAL COUNSEL at ABIOMED INC
- Sold, on record
- $4.8M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 10, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- AXGNAxogen, Inc.EVP & General Counsel
- ABIOMED INCVP & GENERAL COUNSEL
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- AXGN90,000 shares
- ABIOMED INC2,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ABIOMED INCPlan not statedAug 29, 2022 2022
Sold 500 shares at $255.95 ($128k)
Began Marc A, VP & GENERAL COUNSEL
Sold 3.1% of holdings ($4.2M position)15,785 shares leftFirst sale on recordFiling
- 2 Form 4 sale ABIOMED INCPlan not statedNov 4, 2022 +67 days
Sold 2,000 shares at $373.71 ($747k)
Began Marc A, VP & GENERAL COUNSEL
Sold 12.7% of holdings ($5.9M position)13,785 shares leftFiling
- 3 Form 4 sale AXGNNo planDec 9, 2025 +1131 days
Sold 9,278 shares at $31.21 ($290k)
Began Marc A, EVP & General Counsel
No 10b5-1 planSold 22.7% of holdings ($1.3M position)31,507 shares leftFirst sale on recordFiling
- 4 Form 4 sale AXGNUnusualDec 11, 2025 +2 days
Sold 13,222 shares at $30.00 ($397k)
Began Marc A, EVP & General Counsel
No 10b5-1 planSold 42% of holdings ($945k position)18,285 shares leftFiling
- 5 Form 4 sale AXGNRoutineAug 10, 2026 +242 days
Sold 67,500 shares at $47.35 ($3.2M)
Began Marc A, EVP & General Counsel
10b5-1 planSold 57.4% of holdings ($5.6M position)50,135 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12, 2026 | AXGN | EVP & General Counsel | Form 4 sale | 67,500 | $3.2M | 57.4% | Routine | SEC |
| Dec 11, 2025 | Dec 12, 2025 | AXGN | EVP & General Counsel | Form 4 sale | 13,222 | $397k | 42.0% | Unusual | SEC |
| Dec 9, 2025 | Dec 10, 2025 | AXGN | EVP & General Counsel | Form 4 sale | 9,278 | $290k | 22.7% | No plan | SEC |
| Nov 4, 2022 | Nov 8, 2022 | ABIOMED INC | VP & GENERAL COUNSEL | Form 4 sale | 2,000 | $747k | 12.7% | Plan not stated | SEC |
| Aug 29, 2022 | Aug 30, 2022 | ABIOMED INC | VP & GENERAL COUNSEL | Form 4 sale | 500 | $128k | 3.1% | Plan not stated | SEC |